Work

Comparison of efficacy and tolerability of Duloxetine \nvs. Gabapentin in treatment of diabetic peripheral \nneuropathic pain

Year: 2011
Type: dissertation
Study design: Clinical Trial
Abstract: Introduction: Diabetic peripheral neuropathy (DPN) is one of the most common \nsymptomatic, long-term complications in patients with both type 1 and type 2 diabetes \nmellitus, and most common and most debilitating of the diabetic neuropathies. \nDuloxetine, a selective serotonin norepinephrine reuptake inhibitor (SNRI), is effective \nfor the treatment of painful diabetic polyneuropathy. The most common reported side \neffects of duloxetine are nausea, somnolence, dizziness, decreased appetite, and \nconstipation. \nGabapentin is an anticonvulsant effective in peripheral diabetic neuropathic pain. Side \neffects include dizziness, sedation and weight gain. \nMethods: We selected 60 diabetic patients, with peripheral diabetic neuropathic pain, \nincluding of 33 men (mean age=43 years), and 27 women (mean age=42 years). Of \nthese 60 patients 43 patients had been treated with gabapentin and had an inadequate \nresponse after at least 3months of treatment, and 17 patients had been complicated with \nside effects before reaching full dose of Gabapentin. We started Duloxetine 60mg once \ndaily and evaluated the patients� pain improvement after 3months. \nResults: Mean pain score was 6.21 before starting Gabapentin, 5.28 after 3months \ntreatment with Gabapentin, and 4.61 after 3months treatment with Duloxetine (P \nvalue=0.000). Checking HbA1C before and after treatment with Duloxetine showed \nsignificant decrease, but checking blood pressure before and after treatment with \nDuloxetine showed no significant change. \nConclusion: Duloxetine with dose of 60 mg once daily is effective and tolerable for \ndiabetic patients with peripheral diabetic neuropathic pain.
Authors: Zarsanj, Narjes, Salimipour, Hooman, Kalantar Hormozi, Mohamadreza, Motamed, Niloufar
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7017903771
Cites:
Cited by:
Related to: 10